superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2022-03-31
- Valid until
- 2022-06-30
- Published
- 2022-05-04
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 852,100,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals quarterly net income: 973,500,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_41984D40F359, https://asof.is/claim/clm_41984D40F359, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm.
APA
AsOf. (2022). Regeneron Pharmaceuticals quarterly net income: 973,500,000 United States dollar (as of 2022-03-31 (until 2022-06-30)) [Record clm_41984D40F359]. Retrieved November 10, 2026, from https://asof.is/claim/clm_41984D40F359 (source: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm)
BibTeX
@misc{asof_clm_41984D40F359,
author = {AsOf},
title = {Regeneron Pharmaceuticals quarterly net income: 973,500,000 United States dollar},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_41984D40F359}},
note = {Claim clm\_41984D40F359, as of 2022-03-31 (until 2022-06-30); source: https://www.sec.gov/Archives/edgar/data/872589/000180422022000015/0001804220-22-000015-index.htm},
urldate = {2026-11-10}
}Supersedes
On the record
/claim/clm_41984D40F359.md/v1/claims/clm_41984D40F359submit a correction